×

Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody

DC CAFC
  • US 7,682,612 B1
  • Filed: 11/09/1999
  • Issued: 03/23/2010
  • Est. Priority Date: 11/09/1998
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method of treating chronic lymphocytic leukemia in a human patient, comprising administering an anti-CD20 antibody to the patient in an amount effective to treat the chronic lymphocytic leukemia, wherein the method does not include treatment with a radiolabeled anti-CD20 antibody.

View all claims
  • 4 Assignments
Timeline View
Assignment View
    ×
    ×